Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers

Recently, targeted nanoparticles (NPs) have attracted much attention in cancer treatment due to their high potential as carriers for drug delivery. In this article, we present a novel bioconjugate (DOX–AuNPs–Tmab) consisting of gold nanoparticles (AuNPs, 30 nm) attached to chemotherapeutic agent dox...

Descripción completa

Detalles Bibliográficos
Autores principales: Żelechowska-Matysiak, Kinga, Wawrowicz, Kamil, Wierzbicki, Mateusz, Budlewski, Tadeusz, Bilewicz, Aleksander, Majkowska-Pilip, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058186/
https://www.ncbi.nlm.nih.gov/pubmed/36985421
http://dx.doi.org/10.3390/molecules28062451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058186/
https://www.ncbi.nlm.nih.gov/pubmed/36985421
http://dx.doi.org/10.3390/molecules28062451

Ejemplares similares